Medicine and Dentistry
ACE Inhibitor
14%
Albuminuria
7%
All Cause Mortality
9%
Alteplase
6%
Apoplexy
54%
Blood Clot Lysis
12%
Blood Pressure
100%
Blood Pressure Reduction
16%
Brain Ischemia
17%
Cardiovascular Disease
29%
Cardiovascular Risk
18%
Cardiovascular System
40%
Cerebral Hemorrhage
40%
Cerebrovascular Disease
7%
Chronic Kidney Disease
11%
Clinical Trial
10%
Congestive Heart Failure
8%
Creatinine
8%
Diabetes
48%
Diastolic Blood Pressure
6%
Diuretics
9%
Gliclazide
18%
Glomerular Filtration Rate
9%
Hazard Ratio
15%
Hematoma
6%
Hemoglobin A1c
6%
Indapamide
14%
Indapamide Plus Perindopril
17%
Ischemic Heart Disease
9%
Maturity Onset Diabetes of the Young
49%
Meta-Analysis
31%
Microangiopathy
6%
Modified Rankin Scale
8%
Myocardial Infarction
8%
Nephropathy
10%
Observational Study
6%
Odds Ratio
9%
Patient with Diabetes
8%
Patient with Type 2 Diabetes
34%
Perindopril
26%
Placebo
19%
Pooled Analysis
9%
Proportional Hazards Model
7%
Randomized Controlled Trial
18%
Secondary Prevention
6%
Systematic Review
11%
Systolic Blood Pressure
21%
Table Salt
6%
Treatment Effect
6%
Vascular Disease
24%
Pharmacology, Toxicology and Pharmaceutical Science
Albuminuria
5%
All Cause Mortality
18%
Alteplase
17%
Antihypertensive Agent
8%
Brain Hemorrhage
44%
Brain Ischemia
23%
Brain Natriuretic Peptide
6%
Calcium Antagonist
5%
Cardiovascular Disease
30%
Cardiovascular Mortality
7%
Cardiovascular Risk
22%
Cerebrovascular Accident
74%
Cerebrovascular Disease
12%
Chronic Kidney Failure
10%
Clinical Trial
12%
Combination Therapy
10%
Congestive Heart Failure
13%
Creatinine
8%
Diabetes Mellitus
5%
Dipeptidyl Carboxypeptidase Inhibitor
23%
Diseases
7%
Diuretics
16%
Essential Hypertension
12%
Gliclazide
25%
Heart Infarction
15%
Hematoma
12%
Hemoglobin A1c
10%
Hypertension
6%
Indapamide
28%
Indapamide Plus Perindopril
20%
Ischemic Heart Disease
11%
Kidney Disease
11%
Kidney Failure
6%
Leporidae
18%
Malignant Neoplasm
7%
Microangiopathy
6%
Modified Release
12%
Monotherapy
9%
Neuropeptide Y
5%
Non Insulin Dependent Diabetes Mellitus
74%
Noradrenalin
7%
Observational Study
5%
Perindopril
45%
Placebo
38%
Randomized Controlled Trial
20%
Rankin Scale
11%
Systolic Hypertension
9%
Transient Ischemic Attack
6%
Vascular Disease
28%
Vasopressin
5%
Neuroscience
ACE Inhibitor
13%
Alteplase
5%
Antihypertensive Agent
6%
Axon
6%
Baroreceptor
10%
Baroreflex
12%
Blood Plasma
12%
Brain Ischemia
15%
Brainstem
16%
C-Fos
6%
Catecholamine
18%
Cerebral Hemorrhage
42%
Cerebrovascular Accident
52%
Cerebrovascular Disease
9%
Diabetes Mellitus
11%
Diuretic
6%
Epinephrine
12%
Gliclazide
5%
Glutamic Acid
9%
Hematoma
9%
Hemoglobin A1c
7%
Hypertension
35%
Indapamide
9%
Medulla
46%
Medulla Oblongata
8%
Meta-Analysis
10%
Myocardial Infarction
8%
Nerve Conduction
5%
Neuropeptide Y
11%
Norepinephrine
8%
Perindopril
23%
Perindopril/Indapamide
7%
Phenylethanolamine N-Methyltransferase
8%
Placebo
18%
Pressor Response
7%
Randomized Controlled Trial
10%
Serotonergic
8%
Serotonin
11%
Substance P
6%
Sympathetic Nerve
7%
Synapse
7%
Transient Ischemic Attack
6%
Vascular Disease
17%
Vasopressin
5%